ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 622596 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 622596; 2) Community: the network communities that were significantly associated with the response to NSC 622596; 3) Molecule: the relationships between components within communities and NSC 622596; 4) MDR: the compounds that were significantly associated with the NSC 622596.

NSC Compound Enrichment Correlation
NSC 750038 Null 0.0295480456086947 0.51401466
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0295480456086947 0.05978242
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0295480456086947 0.45809196
NSC 757795 BERBERINE CHLORIDE 0.0295480456086947 0.31975798
NSC 87500 Solacongestidine 0.0295480456086947 0.29809379
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.0314734733353265 0.37185475
NSC 111533 Methoxycamptothecin 0.0314734733353265 0.36973248
NSC 113951 6-Bromotoyocamycin 0.0314734733353265 0.41641233
NSC 194618 Benz[a]anthracene-7,12-dione, 1,8-dihydroxy-3-methyl- (7CI, 8CI, 9CI) 0.0314734733353265 0.1548728
NSC 294526 Null 0.0314734733353265 0.36400537
Total:126  Current:99    [First] [Prev] [Next] [Last]